Jefferies More Bullish on Aegerion Pharmaceuticals (AEGR) Following Lipidologists Survey
Tweet Send to a Friend
Jefferies boosted its price target on Buy-rated Aegerion Pharmaceuticals (NASDAQ: AEGR) from $46 to $50 following a survey of U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
